Search Orphan Drug Designations and Approvals
-
| Generic Name: | autologous logic-gated Tmod chimeric antigen receptor (CAR) T cells expressing a carcinoembryonic antigen targeted CAR activator and a human leukocyte antigen serotype A*02 (HLA-A*02) targeted blocker |
|---|---|
| Date Designated: | 02/22/2024 |
| Orphan Designation: | Treatment of germline heterozygous HLA-A*02(+) patients with colorectal cancer that expresses CEA and has lost HLA A*02 expression |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
A2 Biotherapeutics, Inc. 30301 Agoura Road, Suite 210 Agoura Hills, California 91301 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







